Browse by author
Lookup NU author(s): Professor David KavanaghORCiD, Dr Holly Anderson
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Mutations in complement proteins predispose to atypical hemolytic uremic syndrome (aHUS). Mutation screening in aHUS is challenging, because most of the disease-associated mutations are individually rare, and a significant proportion of variants consist of missense mutations of unknown significance. The definitive interpretation of a variant of unknown significance (VUS) is often dependent on a reliable functional assay too time-consuming to be used in a diagnostic screening service. Allied research groups have analyzed these VUSs in aHUS.
Author(s): Kavanagh D, Anderson HE
Publication type: Article
Publication status: Published
Journal: Kidney International
Year: 2012
Volume: 81
Issue: 1
Pages: 11-3
Print publication date: 16/12/2011
ISSN (print): 0085-2538
ISSN (electronic): 1523-1755
Publisher: Nature Publishing Group
URL: http://dx.doi.org/10.1038/ki.2011.330
DOI: 10.1038/ki.2011.330
PubMed id: 22170528
Altmetrics provided by Altmetric